Home » Topics » Conferences

Conferences
RSS

Aplidine evaluated for activity in animal models of lymphoma, prostate and gastric cancer

April 9, 1998

Mechanism of cytotoxic effect of ImmTher

April 9, 1998

PKCbeta inhibitor from Lilly may potentiate effects of radio- and chemotherapy

April 9, 1998

New cell therapy developed at Wistar Institute shows potential as chemotherapy adjuvant

April 9, 1998

Chinese scientists discover novel antitumor antibiotic

April 9, 1998

Klinge identifies new apoptosis inducers active against MDR cell lines

April 9, 1998

Cyclic depsipeptide from Streptomyces induces apoptosis in tumor cells

April 9, 1998

New agents for BPH emerge from Synaptic/Merck & Co. collaboration

April 9, 1998

Flk-1/KDR receptor tyrosine kinase inhibitor SU-5416 characterized at ACS meeting

April 9, 1998

EGFR tyrosine kinase inhibitor from Novartis will proceed to clinical testing

April 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...